BioCryst’s Oral Option To Take On Injectables In HAE Prophylaxis Market

 
• By Joseph Haas
  
FDA Approved typed words on a vintage typewriter
BioCryst gets FDA approval of first oral prophylaxis for HAE
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip